These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1848749)

  • 1. In vitro enhancement of natural killer cell activity against herpesvirus-infected targets in patients with acute lymphocytic leukemia.
    McKolanis JR; Ragab AH; Schmid DS
    Arch Virol; 1991; 117(1-2):17-28. PubMed ID: 1848749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
    Frey JR; Kamber M; Peck R
    Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral blood lymphocytes resistant to Epstein-Barr virus immortalization manifest high natural killer (NK) type activity against NK-resistant target cells.
    Gosselin J; Menezes J; Mercier G; Lamoureux G; Oth D
    Viral Immunol; 1990; 3(1):55-65. PubMed ID: 2153385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of impaired natural killer cell activity of B-chronic lymphocytic leukemia patients by recombinant interleukin-2.
    Kay NE; Zarling J
    Am J Hematol; 1987 Feb; 24(2):161-7. PubMed ID: 3028132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased natural killer cell activity and numbers of Leu-7 and Leu-11b (CD 16)-positive cells in bone marrow of children in remission from acute lymphoblastic leukaemia.
    Sørskaar D; Førre O; Lie SO
    Scand J Immunol; 1989 Jan; 29(1):65-72. PubMed ID: 2466327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of human natural killer cell function by the combined effects of tumor necrosis factor alpha or interleukin-1 and interferon-alpha or interleukin-2.
    Ostensen ME; Thiele DL; Lipsky PE
    J Biol Response Mod; 1989 Feb; 8(1):53-61. PubMed ID: 2493514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of human natural killer cells by herpes simplex virus type 1-infected cells.
    Bishop GA; McCurry L; Schwartz SA; Glorioso JC
    Intervirology; 1987; 28(2):78-88. PubMed ID: 2832348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of interferons and interleukin 2 on natural killing of cytomegalovirus-infected fibroblasts.
    Bandyopadhyay S; Miller DS; Matsumoto-Kobayashi M; Clark SC; Starr SE
    Clin Exp Immunol; 1987 Feb; 67(2):372-82. PubMed ID: 2440628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients.
    Chehimi J; Starr SE; Frank I; Rengaraju M; Jackson SJ; Llanes C; Kobayashi M; Perussia B; Young D; Nickbarg E
    J Exp Med; 1992 Mar; 175(3):789-96. PubMed ID: 1346797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular immunosuppression in children with acute lymphoblastic leukemia: effect of consolidation chemotherapy.
    Komada Y; Zhang SL; Zhou YW; Hanada M; Shibata T; Azuma E; Sakurai M
    Cancer Immunol Immunother; 1992; 35(4):271-6. PubMed ID: 1511462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-alpha enhances cytolytic activity of human natural killer cells.
    Ostensen ME; Thiele DL; Lipsky PE
    J Immunol; 1987 Jun; 138(12):4185-91. PubMed ID: 3108384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
    J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A recycling defect as a characteristic of natural killer cells in childhood acute lymphoblastic leukemia.
    Yabuhara A; Kawai H
    Pediatr Res; 1990 Dec; 28(6):572-8. PubMed ID: 2284152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cells in children with malignant solid tumors. Effect of recombinant interferon-alpha and interleukin-2 on natural killer cell function against tumor cell lines.
    Alvarado CS; Findley HW; Chan WC; Hnath RS; Abdel-Mageed A; Pais RC; Kutner MH; Ragab AH
    Cancer; 1989 Jan; 63(1):83-9. PubMed ID: 2783377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
    van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL
    J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term killing of natural killer-resistant target cells by interferon-alpha-, interferon-gamma-, and interleukin-2-activated natural killer cells.
    Sarzotti M; Klimpel GR; Baron S
    Nat Immun Cell Growth Regul; 1989; 8(2):66-75. PubMed ID: 2503715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individual NK cell clones lyse both tumor cell targets and herpes simplex virus-infected fibroblasts in the absence of interferon.
    Canessa A; Chatterjee S; Whitley RJ; Prasthofer EF; Grossi CE; Tilden AB
    Viral Immunol; 1990; 3(3):217-24. PubMed ID: 1701642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 2- and interferon alpha induced natural killer cell activity as a marker of progression in hairy cell leukemia.
    Bigda J; Mysliwska J; Baran W; Hellmann A; Mysliwski A
    Leuk Lymphoma; 1993 Mar; 9(4-5):371-6. PubMed ID: 8348073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulation of natural killer activity in children with acute lymphoblastic leukaemia.
    Jermy A; Jennings R; Lilleyman JS; Rees RC
    Eur J Cancer Clin Oncol; 1987 Sep; 23(9):1371-7. PubMed ID: 3500050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperation between CD16(Leu-11b)+ NK cells and HLA-DR+ cells in natural killing of herpesvirus-infected fibroblasts.
    Oh SH; Bandyopadhyay S; Miller DS; Starr SE
    J Immunol; 1987 Oct; 139(8):2799-802. PubMed ID: 2821120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.